Clinical Trial Details
| Trial ID: | L4170 |
| Source ID: | NCT00461617 |
| Associated Drug: | Mitiglinide |
| Title: | Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes |
| Interventions: | DRUG: Mitiglinide |
| Outcome Measures: | Primary: Hemoglobin A1C (HbA1C), -2, 0, 4, 8, 10, 12, 16, 20 week | Secondary: Fasting plasma glucose level (FPG), 0, 4, 8, 12, 16, 20 week|Two-hour postprandial glucose level (PPG2), 0, 12, 20 week|One-hour postprandial glucose level (PPG1), 0, 12, 20 week |
| Sponsor/Collaborators: | Sponsor: Kissei Pharmaceutical Co., Ltd. |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE3 |
| Enrollment: | 291 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT |
| Start Date: | 2006-08 |
| Completion Date: | 2007-07 |
| Results First Posted: | |
| Last Update Posted: | 2008-10-21 |
| Locations: | |
| URL: | https://clinicaltrials.gov/show/NCT00461617 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|